NH News and Press, NantHealth Inc.

2023-05-23 10:08:04 ET Gainers: CohBar ( CWBR ) +157% . Ocean Biomedical ( OCEA ) +79% . Shuttle Pharmaceuticals ( SHPH ) +46% . Icosavax ( ICVX ) +31% . Recursion Pharmaceuticals ( RXRX ) +20% . Losers: NantHealth ( ...

2023-05-03 13:05:45 ET Gainers: ImmunoGen ( IMGN ) +124% . GD Culture Group Limited ( GDC ) +115% . Aptorum Group Limited ( APM ) +92% . Aceragen ( ACGN ) +77% . NantHealth ( NH ) +57% . Sentage Holdings ( SNTG ) +61% ...

HITRUST Certification validates NantHealth’s commitment to aligning with key regulations and protecting sensitive information NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions transforming complex data into actionable insights, today announced its E...

2023-03-06 09:20:36 ET NantHealth ( NASDAQ: NH ) entered into a credit agreement for a new senior secured term loan in principal amount of $22.5M. Net proceeds to be used for funding its existing businesses and for general corporate purposes. The term loan facility was...

NantHealth , Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the entry into a credit agreement for a new senior secured term loan in an aggregate principal amount of $22.5 million. The company...

Meridian 2023 is a look into the future of network monitoring, centered around simplification The OpenNMS Group, Inc ., a subsidiary of NantHealth, Inc. (NASDAQ: NH), today announced the release of OpenNMS Meridian 2023 . With this major release, the fully open source Meri...

NantHealth , Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that the company has implemented a reverse stock split at a ratio of 1-for-15, which is expected to be effective 5 p.m. Eastern Tim...

NantHealth, Inc. (NH) Q3 2022 Earnings Conference Call November 03, 2022 04:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Conference Call Participants Present...

NantHealth press release ( NASDAQ: NH ): Q3 Non-GAAP EPS of -$0.12. Revenue of $16.6M (+15.3% Y/Y). For further details see: NantHealth Non-GAAP EPS of -$0.12, revenue of $16.6M

Q3 2022 Financial and Operational Highlights: Total net revenue was $16.6 million Gross profit was $9.7 million, or 58% of total revenue The company’s Eviti Connect platform earned full URAC accreditation for Health Utilization Management, through 2025 Maryl...